Search research articles
Contact Us
Filters
Showing results (21-30 of 84) with videos related to
Page
of 9
Sort By:
Journal of Blood Medicine
|
February 10, 2017
Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan
Hideaki Yoshimura, Masaaki Hotta, Takahisa Nakanishi, et al.
Cancer Medicine
|
January 12, 2026
Real-World Outcomes of Polatuzumab Vedotin Plus R-CHP Versus R-CHOP-Based Regimens in Japanese Patients With Untreated Diffuse Large B-Cell Lymphoma
Masaaki Hotta, Atsushi Satake, Ayako Iwama, et al.
Leukemia Research
|
July 29, 2011
Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation
Jun Nakata, Masaya Okada, Hiroya Tamaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 25, 2012
Cutting edge: IL-2 signals determine the degree of TCR signaling necessary to support regulatory T cell proliferation in vivo
Tao Zou, Atsushi Satake, Evann Corbo-Rodgers, et al.
Journal of Blood Medicine
|
February 7, 2018
Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma
Shosaku Nomura, Tomoki Ito, Hideaki Yoshimura, et al.
Journal of Blood Medicine
|
August 3, 2019
The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells
Kayoko Kibata, Tomoki Ito, Muneo Inaba, et al.
Blood Advances
|
August 8, 2020
Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses
Vien Phan, Tomoki Ito, Muneo Inaba, et al.
European Journal of Immunology
|
July 4, 2019
Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression
Noriko Inagaki-Katashiba, Tomoki Ito, Muneo Inaba, et al.
Journal of Gastroenterology
|
March 7, 2018
Induction of PIR-A/B<sup>+</sup> DCs in the in vitro inflammatory condition and their immunoregulatory function
Fumi Matsui, Muneo Inaba, Kazushige Uchida, et al.
Molecular and Clinical Oncology
|
June 23, 2016
Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia
Yoshiko Azuma, Aya Nakaya, Masaaki Hotta, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 84) with videos related to
Sort By:
Page
of 9
Journal of Blood Medicine
|
February 10, 2017
Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan
Hideaki Yoshimura, Masaaki Hotta, Takahisa Nakanishi, et al.
Cancer Medicine
|
January 12, 2026
Real-World Outcomes of Polatuzumab Vedotin Plus R-CHP Versus R-CHOP-Based Regimens in Japanese Patients With Untreated Diffuse Large B-Cell Lymphoma
Masaaki Hotta, Atsushi Satake, Ayako Iwama, et al.
Leukemia Research
|
July 29, 2011
Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation
Jun Nakata, Masaya Okada, Hiroya Tamaki, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 25, 2012
Cutting edge: IL-2 signals determine the degree of TCR signaling necessary to support regulatory T cell proliferation in vivo
Tao Zou, Atsushi Satake, Evann Corbo-Rodgers, et al.
Journal of Blood Medicine
|
February 7, 2018
Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma
Shosaku Nomura, Tomoki Ito, Hideaki Yoshimura, et al.
Journal of Blood Medicine
|
August 3, 2019
The immunomodulatory-drug, lenalidomide, sustains and enhances interferon-α production by human plasmacytoid dendritic cells
Kayoko Kibata, Tomoki Ito, Muneo Inaba, et al.
Blood Advances
|
August 8, 2020
Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses
Vien Phan, Tomoki Ito, Muneo Inaba, et al.
European Journal of Immunology
|
July 4, 2019
Statins can suppress DC-mediated Th2 responses through the repression of OX40-ligand and CCL17 expression
Noriko Inagaki-Katashiba, Tomoki Ito, Muneo Inaba, et al.
Journal of Gastroenterology
|
March 7, 2018
Induction of PIR-A/B<sup>+</sup> DCs in the in vitro inflammatory condition and their immunoregulatory function
Fumi Matsui, Muneo Inaba, Kazushige Uchida, et al.
Molecular and Clinical Oncology
|
June 23, 2016
Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia
Yoshiko Azuma, Aya Nakaya, Masaaki Hotta, et al.
Page
of 9